well picked up I am still looking through what is “hyperbole “ versus clinical fact. What struck me was the reference to CA125 as SOC
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark, page-31
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.015(4.17%) |
Mkt cap ! $28.15M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.5¢ | 33.0¢ | $78.77K | 232.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9393 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 34999 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| COV (ASX) Chart |